Adjusted EBITDA increased 61.4% to $31.2 million in the third quarter of 2024 from $19.3 million in the same period of 2023. Adjusted EBITDA increased 26.0% to $75.9 million for the nine-month period ...
Q3 2024 Earnings Call Transcript November 4, 2024 Enfusion, Inc. reports earnings inline with expectations. Reported EPS is $0.05 EPS, expectations were $0.05. Operator: Good morning, ladies and ...
MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability ...